<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99131">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01897558</url>
  </required_header>
  <id_info>
    <org_study_id>GER-EP-012</org_study_id>
    <nct_id>NCT01897558</nct_id>
  </id_info>
  <brief_title>Myocardial Micro-damage in Relation to Active and Passive Fixation Pacemaker Electrodes</brief_title>
  <acronym>PACMAN</acronym>
  <official_title>Effect of Passive Versus Active Fixation Leads on the Magnitude of Troponin Release After Pacemaker Implantation (PACMAN Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pacemaker electrodes are either equipped with tines (passive fixation) or with a screw
      (active fixation) for initial fixation in the patient´s heart. Both types of electrodes
      provide similar results in a long-term follow-up and the use of one or the other electrode
      type in many instances is mainly based on the implanter´s preference. The PACMAN-trial
      investigates whether the two lead types are associated with different amounts of myocardial
      micro-damage during implantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>high-sensitive Troponin T</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">290</enrollment>
  <condition>Bradyarrhythmia</condition>
  <arm_group>
    <arm_group_label>Ventricular pacemaker electrode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>receives an active fixation ventricular pacemaker electrode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Passive fixation ventricular pacemaker electrode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>receives a passive fixation ventricular pacemaker electrode</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation</intervention_name>
    <arm_group_label>Ventricular pacemaker electrode</arm_group_label>
    <arm_group_label>Passive fixation ventricular pacemaker electrode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  de-novo implantation of a pacemaker system

        Exclusion Criteria:

          -  AAI pacing or cardiac resynchronization therapy

          -  ICD indication

          -  temporary pacing

          -  lead revision

          -  right ventricular pacing aimed from alternative pacing sites (other than the apex)

          -  lead revision

          -  severe tricuspid valve regurgitation

          -  previous myocardial infarction, coronary intervention, stroke, cardioversion or
             ablation in the presence of elevated troponin levels

          -  dialysis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christof Kolb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christof Kolb, MD</last_name>
    <phone>0049891218</phone>
    <phone_ext>2020</phone_ext>
    <email>kolb@dhm.mhn.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hrvoje Vrazic, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Kempten</name>
      <address>
        <city>Kempten</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Karch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Landshut-Achdorf</name>
      <address>
        <city>Landhut</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Zrenner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christof Kolb, MD</last_name>
      <phone>0049891218</phone>
      <phone_ext>2020</phone_ext>
      <email>kolb@dhm.mhn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kenri Hospital</name>
      <address>
        <city>Mishima</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitani, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Croatia</country>
    <country>Germany</country>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 16, 2014</lastchanged_date>
  <firstreceived_date>May 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
